Immediate Impact
1 by Nobel laureates 11 hit
Citing Papers
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
2022 Hit
The Next Decade of Immune Checkpoint Therapy
2021 HitNobel
Works of Annette M. Lim being referenced
Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)
2019